Persistent HPV16 infection

Clinical trials for Persistent HPV16 infection explained in plain language.

Never miss a new study

Get alerted when new Persistent HPV16 infection trials appear

Sign up with your email to follow new studies for Persistent HPV16 infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

Experimental shot aims to clear stubborn HPV infection in the anal region

Disease control Recruiting now

This early-stage trial tests an experimental therapy called NWRD09 in 10 adults aged 18 to 60 who have had a persistent HPV16 infection in the anal area for at least a year. The therapy is given as an injection and is designed to help the body clear the virus. The study primarily…

Matched conditions: PERSISTENT HPV16 INFECTION

Phase 1 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

Persistent HPV16 infection

Get alerted when new Persistent HPV16 infection trials appear

Experimental shot aims to clear stubborn HPV infection in the anal region